(IYH) iShares U.S. Healthcare - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US4642877629

Healthcare, Pharma, Biotech, Medical, Devices

Description: IYH iShares U.S. Healthcare August 05, 2025

The iShares U.S. Healthcare ETF (NYSE ARCA:IYH) is an exchange-traded fund that tracks the performance of the healthcare sector in the U.S. equity market, investing at least 80% of its assets in the underlying indexs component securities.

As a non-diversified fund, IYHs performance is closely tied to the healthcare sector, which includes pharmaceuticals, biotechnology, healthcare equipment, and healthcare services. Key Performance Indicators (KPIs) to monitor for this ETF include sector allocation, top holdings, and expense ratio. The funds underlying index is likely market-cap weighted, meaning that the largest healthcare companies have a greater influence on the funds performance.

To evaluate IYHs potential, we can examine its tracking error, which measures the difference between the funds returns and those of its underlying index. A lower tracking error indicates that the fund is more effectively tracking its benchmark. Additionally, we can analyze the funds dividend yield, which can provide insight into the income generated by the underlying holdings.

From a portfolio construction perspective, IYH can be used as a sector-specific allocation within a broader investment portfolio. Investors seeking to gain exposure to the healthcare sector can use IYH as a tactical or strategic holding, depending on their investment objectives and risk tolerance. Key metrics to consider when evaluating IYHs suitability include its correlation with other portfolio holdings, as well as its overall contribution to portfolio risk and return.

IYH ETF Overview

Market Cap in USD 2,877m
Category Health
TER 0.40%
IPO / Inception 2000-06-12

IYH ETF Ratings

Growth Rating 13.8%
Fundamental -
Dividend Rating 48.2%
Return 12m vs S&P 500 -16.8%
Analyst Rating -

IYH Dividends

Dividend Yield 12m 1.17%
Yield on Cost 5y 1.74%
Annual Growth 5y 6.18%
Payout Consistency 95.1%
Payout Ratio %

IYH Growth Ratios

Growth Correlation 3m 87.6%
Growth Correlation 12m -44.7%
Growth Correlation 5y 77.1%
CAGR 5y 5.04%
CAGR/Max DD 3y (Calmar Ratio) 0.28
CAGR/Mean DD 3y (Pain Ratio) 0.90
Sharpe Ratio 12m 0.26
Alpha -17.12
Beta 0.710
Volatility 11.69%
Current Volume 201.1k
Average Volume 20d 551k
Stop Loss 59.8 (-3.1%)
Signal 0.49

What is the price of IYH shares?

As of October 28, 2025, the stock is trading at USD 61.69 with a total of 201,087 shares traded.
Over the past week, the price has changed by +1.06%, over one month by +7.66%, over three months by +8.76% and over the past year by -0.60%.

Is iShares U.S. Healthcare a good stock to buy?

Neither. Based on ValueRay´s Analyses, iShares U.S. Healthcare is currently (October 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 13.79 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of IYH is around 57.63 USD . This means that IYH is currently overvalued and has a potential downside of -6.58%.

Is IYH a buy, sell or hold?

iShares U.S. Healthcare has no consensus analysts rating.

What are the forecasts/targets for the IYH price?

Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 64.3 4.3%

IYH Fundamental Data Overview October 20, 2025

Market Cap USD = 2.88b (2.88b USD * 1.0 USD.USD)
Beta = 0.71
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 2.88b USD (2.88b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 2.88b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 2.88b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.63% (E(2.88b)/V(2.88b) * Re(8.63%) + (debt-free company))
Discount Rate = 8.63% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)

Additional Sources for IYH ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle